LINC00923

Across TCGA pan-cancer cohorts, LINC00923 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC00923’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC00923 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00923 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

KIRC, KICH, and BRCA are the cancer types where LINC00923 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00923 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	−0.095	<.001	9	view →
KICH	Female	All	−0.185	<.001	6	view →
BRCA	All	III,IV	−0.135	<.001	6	view →
HNSC	All	All	+0.108	.009	6	view →
LUAD	Female	II,III,IV	−0.184	<.001	5	view →
STAD	All	All	−0.127	.006	3	view →
READ	All	III,IV	−0.320	.044	2	view →
UCEC	All	IV	−0.285	.031	2	view →
LIHC	All	All	+0.103	.018	2	view →
COAD	Female	III,IV	−0.438	.005	1	view →
BLCA	All	IV	−0.255	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC00923–KIRC

Open the KIRC breakdown →